ARTIVION INC (AORT) Stock Fundamental Analysis
USA - NYSE:AORT - US2289031005 - Common Stock
44.83 USD
-0.29 (-0.64%)
44.83 USD
0 (0%)
AORT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AORT had negative earnings in the past year.
In the past year AORT had a positive cash flow from operations.
In the past 5 years AORT always reported negative net income.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
AORT's Return On Assets of -2.13% is fine compared to the rest of the industry. AORT outperforms 69.68% of its industry peers.
Looking at the Return On Equity, with a value of -4.26%, AORT is in the better half of the industry, outperforming 70.74% of the companies in the same industry.
AORT's Return On Invested Capital of 2.15% is fine compared to the rest of the industry. AORT outperforms 69.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROIC | 2.15% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of AORT (5.18%) is better than 69.68% of its industry peers.
In the last couple of years the Operating Margin of AORT has grown nicely.
Looking at the Gross Margin, with a value of 63.99%, AORT is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AORT has more shares outstanding than it did 1 year ago.
AORT has more shares outstanding than it did 5 years ago.
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.88 indicates that AORT is not in any danger for bankruptcy at the moment.
AORT's Altman-Z score of 3.88 is fine compared to the rest of the industry. AORT outperforms 75.00% of its industry peers.
AORT has a debt to FCF ratio of 28.63. This is a negative value and a sign of low solvency as AORT would need 28.63 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 28.63, AORT is doing good in the industry, outperforming 68.09% of the companies in the same industry.
A Debt/Equity ratio of 0.52 indicates that AORT is somewhat dependend on debt financing.
AORT has a Debt to Equity ratio (0.52) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Altman-Z | 3.88 |
ROIC/WACC0.25
WACC8.43%
2.3 Liquidity
AORT has a Current Ratio of 4.78. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.78, AORT is in the better half of the industry, outperforming 77.13% of the companies in the same industry.
A Quick Ratio of 3.48 indicates that AORT has no problem at all paying its short term obligations.
AORT has a Quick ratio of 3.48. This is in the better half of the industry: AORT outperforms 71.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -85.71% in the last year.
Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 9.75% in the last year.
AORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.06% yearly.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
Based on estimates for the next years, AORT will show a very strong growth in Earnings Per Share. The EPS will grow by 46.79% on average per year.
AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.19% yearly.
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AORT is valuated quite expensively with a Price/Forward Earnings ratio of 110.83.
AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 65.43% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.98. AORT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 110.83 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than the industry average as 66.49% of the companies are valued more expensively.
65.96% of the companies in the same industry are more expensive than AORT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 276.01 | ||
| EV/EBITDA | 51.71 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.48%
EPS Next 3Y51.07%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
44.83
-0.29 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners4.41%
Ins Owner Change-4.25%
Market Cap2.12B
Revenue(TTM)388.54M
Net Income(TTM)-17.90M
Analysts83.08
Price Target46.16 (2.97%)
Short Float %3.27%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1009.98%
Min EPS beat(2)91.71%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)376.32%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)158.13%
EPS beat(12)8
Avg EPS beat(12)112.3%
EPS beat(16)10
Avg EPS beat(16)39.11%
Revenue beat(2)2
Avg Revenue beat(2)2.37%
Min Revenue beat(2)2.16%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)5
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.53%
PT rev (1m)3.6%
PT rev (3m)38.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.27%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)2.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 110.83 | ||
| P/S | 5.22 | ||
| P/FCF | 276.01 | ||
| P/OCF | 107.63 | ||
| P/B | 5.04 | ||
| P/tB | 276.12 | ||
| EV/EBITDA | 51.71 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.4
Fwd EY0.9%
FCF(TTM)0.16
FCFY0.36%
OCF(TTM)0.42
OCFY0.93%
SpS8.58
BVpS8.9
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROCE | 2.72% | ||
| ROIC | 2.15% | ||
| ROICexc | 2.31% | ||
| ROICexgc | 5.42% | ||
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% | ||
| FCFM | 1.89% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 51.26% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 | ||
| Altman-Z | 3.88 |
F-Score4
WACC8.43%
ROIC/WACC0.25
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue 1Y (TTM)9.75%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
EBIT growth 1Y-22.98%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year112.29%
EBIT Next 3Y43.08%
EBIT Next 5Y32.16%
FCF growth 1Y224.1%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y335.36%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 4 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 5 / 10.